Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Michael J. Rybak, PharmD, PhD, MPH

Professor
Eugene Applebaum College of Pharmacy and Health Sciences

Disclosure(s): No financial relationships to disclose

Poster(s):

633 - Eravacycline Use in Immunocompromised Patients: Multicenter Evaluation of Clinical and Safety Endpoints
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET
679 - Traditional vs. Alternative Agents in Patients with Lower Respiratory Tract Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa Susceptible to Traditional Agents
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET
1422 - A Multi-Center Evaluation of Omadacycline for Multi-Drug Resistant Infections
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET
1691 - Bacteriophage and Protein Synthesis Pathway Inhibitor Combinations: Antibiotic mechanism of action drives antagonistic interactions
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET
1703 - Efficacy of Selected Metabolic Inhibitors for the Prevention and Resensitization of High-Level Daptomycin Resistance in Streptococcus mitis-oralis In Vitro and in an Ex Vivo Simulated Endocarditis Model
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET